Assessing The Novel Antitrust Claims In Humira Case
Drug pricing and patent protection have attracted interest among policymakers in recent months. An issue gaining increased attention has been the use of so-called patent thickets to allegedly delay entry by...To view the full article, register now.
Already a subscriber? Click here to view full article